
Rep. Rob Wittman @RobWittman
I would support standalone bipartisan provisions that: 1. Penalize branded drug makers that withhold samples from generic manufacturers 2. Ban pay-for-delay agreements 3. Limit first-approved generic makers’ ability to stall another rival’s launch — PolitiTweet.org